ascopubs.org

A phase 1/2 study of KSQ-004EX: Autologous tumor infiltrating lymphocytes, engineered to inactivate genes encoding SOCS1 and Regnase-1, in patients with select advanced solid ...

Autologous tumor-infiltrating lymphocytes (HS-IT101) with low-dose lymphodepletion and IL-2 infusion for the treatment of advanced solid tumors: A phase I clinical trial. This is an ASCO Meeting ...
Hosted on MSN

Observation of a new phase of matter at the boundary between solid and liquid

The melting of materials seems like a simple phenomenon. However, when their thickness is reduced to just a few atoms, established rules waver. In this two-dimensional mode, new states emerge between ...
ascopubs.org

A phase 1 dose escalation trial of ex-vivo expanded allogeneic cord blood–derived natural killer cell immunotherapy for pediatric solid tumor malignancies.

A pilot study of lymphodepletion intensity for PBMC-derived, neoantigen-specific CD8+ T cells (Neo-Ts) therapy in patients with advanced solid tumors. This is an ASCO Meeting Abstract from the 2023 ...